Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Supplied as a lyophilized powder, it is formulated to support stability and maintain a high level of purity for research applications. Cartalax is intended solely for in vitro use by qualified professionals performing studies in controlled laboratory settings.
